Discussion  by unknown
include complete long-term angiographic assessment of pa-
tency. Finally, the number of patients enrolled was small.
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Discussion
Dr Ralph J. Damiano, Jr (St. Louis, Mo). I would like to con-
gratulate Dr Kappert and his colleagues for providing long-term fol-
low-up on this very important cohort of patients and also for their
pioneering work in the field.
It is interesting, now, getting on almost 10 years since the first
robotic coronary procedures were done in both Europe and the
United States, that we can begin to look at some long-term fol-
low-up. It also is a bit humbling to look at how small the series
have remained. This probably is the biggest word of caution before
people go out and embark on these programs themselves.
I have a number of questions. I will ask them one at a time.
First, robotic technology was introduced to enhance dexterity.
This was the basic premise for the adoption of these very expensive
systems. However, it was very clearly shown in an experimental
model by Dr Volkmar Falk several years ago, which I am sure
you are aware of, that robotic instrumentation actually is a lot worse
than doing it by hand in the beating-heart environment; that is, the
error rate with robotics was significantly higher than with manual in-
strumentation, so actually it reduced dexterity in this environment.
Also, in the clinical trial of the ZEUS system (Computer Motion,
Inc, Goleta, Calif), which was not as sophisticated a system as the
Intuitive da Vinci system, the off-pump patency was significantly
worse.
You had two groups of patients. In the first group the heart was
arrested and in the second it was beating. If you separated the groups
and told us what the major adverse event rate or target revasculari-
zation rate was just on your beating-heart group, can you separate
the 8 arrested-heart patients from the beating-heart ones? I think
that is an important differentiation for this technology. These sys-
tems do not seem to respond well when there is any type of motion.
Have you looked at these groups separately?
Dr Kappert. I think Dr Cichon can answer this question. He did
nearly 100% of the procedures by himself.
Dr Romuald Cichon (Dresden, Germany). Thank you very
much. I am the senior partner of my friend.
The first part of the question concerned dexterity. As you know,
we have augmentation of almost 10 times using this kind of a robotic.
We have a filter to mask the tremor. Thus I do not believe that with
good stabilization dexterity will be lessened with this system. How-
ever, the crucial aspect of this answer would be good stability and
good stabilization of the cardiac wall.
Your second question concerned off-pump versus on-pump
techniques. Of course, we started with the on-pump technique in
the very early days. But somehow, aiming to the goal of minimally
invasive cardiac surgery and going back to the on-pump era felt
somehow unfair. After we achieved a good sequence to the proce-
dure, which allowed us, in a considerable time, to perform the whole
operation, we switched to the off-pump technique. There was quite
a rocky ride. At that time, we had only the No. 4 prototype of the
stabilizer that we were developing. Now we have the No. 7 proto-
type, as I recall. This is the kind of development that we got.
Basically, thatwas theworst part of the story.With augmentationof
up to 10 times, even a very small movement seems like an earthquake.
Dr Damiano. I guess I still did not get an answer to my question.
If you looked at the stenotic vessels and the ones that needed revas-
cularization, were they all in the beating-heart group? If so, your de-
nominator then is much less and then your rate of major adverse
events may be much higher.
My question is, were the adverse events clustered in the beating-
heart population? Both experimental data would suggest it may be
worse, as did the initial clinical work with the ZEUS system that
has been published previously. If you looked at it separately, what
did you see?
DrCichon.Unfortunately, we did not see any difference. In both
of the groups, we had one graft that failed, which probably was
related to poor handling in the preparation of both of the thoracic ar-
teries. Again, this series of 8 cases and then 30 cases is too small to
allow us to very distinctly differentiate those complications. The
only difference that you have seen was the progressive coronary dis-
ease in the group of off-pump operations, but in a natural way there
were simply more patients involved.
Dr Damiano. If we had catheterization data on everyone, we
really could get a good idea of patency. Unfortunately, few patients
in this trial had a postoperative catheterization. But you actually do
have catheterization data on, I would estimate, at least 7 of the pa-
tients, because those are the patients who had either a myocardial in-
farction or target vessel revascularization. If you just looked at the
catheterization data you have, what would be the patency rate of
that small cohort?
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Dr Kappert. What would it be?
DrDamiano.And stenosis. You are obviously picking a selected
group. But you do have catheterization data on a part of this group,
so I was surprised not to see that presented.
Dr Cichon. We treated those patients as we did any other pa-
tients with coronary disease treated in our clinic. We did not perform
coronary angiography in all the patients. Our practice is to screen
a patient for angiography if there is an ischemic event. Otherwise,
we do not do angiography. Thus the 7 patients whom we have
seen are the patients who had a problem with ischemia. In most
cases, angiography was done more than 6 months after the opera-
tion. Those are the data that were presented.
DrDamiano. It just was unclear. You did more than one graft on
some of those patients, so I was just wondering whether you had the
total number of grafts that were visualized by angiography at late
follow-up and how many of those had either stenosis or occlusion.
This would be another interesting number. It is very possible in your
group that you may have had a number of asymptomatic occlusions
that you would have been unaware of had the patients not come back
for follow-up.
DrCichon.Well, of course, we can exclude it; however, angiogra-
phy is not the only parameter of cardiac ischemia or the diagnosis of
cardiac ischemia.Wehaveother parameters thatweused as our routine.
Dr Damiano. I did not see those data. Are you saying that all the
patients had routine stress tests?
DrCichon.Well, of course, they had echocardiography, electro-
cardiography, and enzyme monitoring. All of those patients were
monitored in the standard manner used in every patient in our clinic.
Dr Damiano. I guess I’m just trying to get a better feel for what
was actually the patency rate in this cohort.
I would like to finish with a question. This is a very highly se-
lected group, 1% of your volume. It is all patients with principally
single-vessel disease, and I am sure you mentioned that you took
even the best of that group. This was a lower risk group than your
normal cohort, and I assume they all had an excellent-quality
LAD or you would not have put them in this initial trial. With this
in mind, I would like to emphasize a word of caution. The reinter-
vention rate of 12% at 5 years in this type of a cohort, particularly
since there was not good angiographic follow-up, is not great. I
do agree with your final comment that these procedures should be
approached cautiously. This is hardly being done anywhere in the
world, but certainly if it is being done, it should be done in very
highly specialized centers that have tremendous dedication, as you
have had, to try to develop the technology. My own impression is
that there are very inherent limitations of robotics. The present
robotic systems in a beating-heart environment actually decrease
your dexterity.
Besides anastomotic devices, which I agree would be an im-
provement, what else could be enhanced with these robotic
systems that could improve the results in the beating-heart
situation?
DrKappert. I believe the first (and very important) thing that we
missed from that day, basically up to today, is a sufficient number
and quality of synergic instrumentation. At that time we started
with 9 instruments suitable for the robotic system. Today we
have, I believe, 40, and we are not done by far with the instrum-
entation. That is probably the most important thing that we have
to improve. I see an immense area for industry to develop. However,
I know it is very difficult at that time.
On the other hand, the overall improvement of the system, with
a fourth arm right now, is also increasing the ability to use this in
a much safer manner.
Dr Valavanur Subramanian (New York, NY). I have three
points of not just caution, but help, from the days of MIDCAB.
Very early on, we showed that a good stabilization equals a good pa-
tency. We have graded the stabilization as A, B, and C and have
looked at that. By that I mean not only the mechanical stabilization
but also the internal stabilization of the artery that you are going to
sew. We presented information at the American Heart Association
meeting in 1996 about the shunted group and nonshunted group
and a MIDCAB, and there is tremendous difference.
Second, anybody who does beating-heart surgery through a min-
imally invasive approach must have a controlled angiogram. By that
I mean I do not think you should have just a fixed, given patency.
We again did some work on looking at minimum luminal diameter,
waist stenosis, toe stenosis, and heel stenosis, just like interventional
cardiologists will do, because it did enhance our technical perfor-
mance to do a better MIDCAB operation. Thus I think it is not
enough to just have patency.
We also have some indication that it correlates very well with
a long-term patency late rate in our own group and the MIDCAB
group. Therefore, I would say that if you are going to do closed chest
heart surgery you must have a controlled angiogram in these pa-
tients, of some period, and evaluate it very carefully, not just the pa-
tency. I think you should look in the details of the anastomotic
milieu, the stenosis, where the stenosis is, and the luminal diameter,
just as interventional cardiologists do, who have perfected their stay-
ing technique, to a point where they do not believe that 30% is
enough. It is important for us to rigorously look at these techniques
to have good results. Unless you do that, you will not learn what the
problems are with TECAB and will not be able to improve.
Did you use a shunt in some of these patients? It does help you to
place the precise stitches. We are doing suture technique with the
TECAB. Does it help you to put a shunt in so that you can control
your anastomotic milieu?
Dr Cichon. Yes, we did use a shunt in some of those patients.
Dr Subramanian. Did you see a difference?
Dr Cichon. Not too much, because the main problem with the
suturing was still good stabilization. It did help us. However, the
mean anastomotic time was about 14 minutes, so we did not think
that we were going to do too much damage to the vessel.
Dr Vaughn A. Starnes (Los Angeles, Calif). I have just one
additional comment. Having worked with the robot a fair amount,
I think that the coupling devices will help with tactile feedback
and handling the tissues, handling the sutures. Sometimes I think
we create stenosis on the suture line by trying to use general methods
that we normally use with hand dexterity and I just do not think are
applicable with the robotic system.
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